Eli Lilly and Co. warns about liver-related problems with its depression drug, Cymbalta.
A new label for the antidepressant, known generically as duloxetine, also includes reports of hepatitis, jaundice and other liver-related problems in patients using the drug, the U.S. Food and Drug Administration says on its Web site
